Patents by Inventor Anders Kanstrup

Anders Kanstrup has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Heterocyclic compounds that are inhibitors of the enzyme DPP-IV
    Publication number: 20050148606
    Abstract: The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV of formula I, pharmaceutical compositions comprising the compounds and the use of such compounds for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.
    Type: Application
    Filed: March 2, 2005
    Publication date: July 7, 2005
    Inventors: Anders Kanstrup, Christian Sams, Jane Lundbeck, Lise Christiansen, Marit Kristiansen
  • Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
    Patent number: 6645995
    Abstract: Described are compounds of formula I wherein at least one of the bonds in the five-membered ring is a double bond; B is any alpha or beta amino acid connected to the ring with an amide or peptide bond; or a salt thereof with a pharmaceutically acceptable acid or base. Pharmaceutical compositions containing these compounds are also described. These compounds are useful for treating type II diabetes.
    Type: Grant
    Filed: February 8, 2002
    Date of Patent: November 11, 2003
    Assignee: Novo Nordisk A/S
    Inventors: Anders Kanstrup, Jane Marie Lundbeck, Lise Brown Christiansen
  • Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
    Publication number: 20020103384
    Abstract: Described are compounds of formula I 1
    Type: Application
    Filed: February 8, 2002
    Publication date: August 1, 2002
    Inventors: Anders Kanstrup, Jane Marie Lundbeck, Lise Brown Christiansen
  • Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
    Patent number: 6380398
    Abstract: Described are compounds of formula I wherein at least one of the bonds in the five-membered ring is a double bond; B is any alpha or beta amino acid connected to the ring with an amide or peptide bond; or a salt thereof with a pharmaceutically acceptable acid or base. Pharmaceutical compositions containing these compounds are also described. These compounds are useful for treating type II diabetes.
    Type: Grant
    Filed: January 23, 2001
    Date of Patent: April 30, 2002
    Assignee: Novo Nordisk A/S
    Inventors: Anders Kanstrup, Jane Marie Lundbeck, Lise Brown Christiansen
  • cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
    Patent number: 6316494
    Abstract: The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: November 13, 2001
    Assignee: Novo Nordisk A/S
    Inventors: Poul Jacobsen, Svend Treppendahl, Paul Stanley Bury, Anders Kanstrup, Lise Brown Christiansen
  • New therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV
    Publication number: 20010031780
    Abstract: Described are compounds of formula I 1
    Type: Application
    Filed: January 23, 2001
    Publication date: October 18, 2001
    Inventors: Anders Kanstrup, Jane Marie Lundbeck, Lise Brown Christiansen
  • NOVEL CIS-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
    Publication number: 20010021710
    Abstract: The present invention relates to therapeutically active compounds of formula I 1
    Type: Application
    Filed: October 27, 1997
    Publication date: September 13, 2001
    Inventors: POUL JACOBSEN, SVEND TREPPENDAHL, PAUL STANLEY BURY, ANDERS KANSTRUP, LISE BROWN CHRISTIANSEN
  • Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
    Patent number: 6080754
    Abstract: The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: June 27, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Anker Steen Jorgensen, Poul Jacobsen, Lise Brown Christiansen, Paul Stanley Bury, Anders Kanstrup
  • Pyrrolo [2,1,5-cd] indolizine derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
    Patent number: 6075036
    Abstract: The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
    Type: Grant
    Filed: June 1, 1998
    Date of Patent: June 13, 2000
    Assignees: Novo Nordisk, Karo Bio AB
    Inventors: Anker Steen Jorgensen, Poul Jacobsen, Lise Brown Christiansen, Paul Stanley Bury, Anders Kanstrup
  • cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
    Patent number: 6043269
    Abstract: The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: March 28, 2000
    Assignee: Novo Nordisk A/S
    Inventors: Poul Jacobsen, Svend Treppendahl, Paul Stanley Bury, Anders Kanstrup, Lise Brown Christiansen
  • Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
    Patent number: 5994390
    Abstract: The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: November 30, 1999
    Assignee: Novo Nordisk
    Inventors: Poul Jacobsen, Svend Treppendahl, Paul Stanley Bury, Anders Kanstrup, Lise Brown Christiansen
  • (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
    Patent number: 5985306
    Abstract: The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: November 16, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Poul Jacobsen, Svend Treppendahl, Paul Stanley Bury, Anders Kanstrup, Lise Brown Christiansen
  • Cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
    Patent number: 5958967
    Abstract: The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: September 28, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Poul Jacobsen, Svend Treppendahl, Paul Stanley Bury, Anders Kanstrup, Lise Brown Christiansen
  • Heterocyclic compounds, their preparation and use
    Patent number: 5945417
    Abstract: The present invention relates to a method of treating a disease in the central nervous system via the metabotropic glutamate receptor system, the use of the known as well as novel pyridino(2,3-b) indoles (formula Ib) for the preparation of a medicament for treating said diseases, novel therapeutic active pyridino(2,3-b) indoles, a method for preparing the same and pharmaceutical compositions comprising these compounds.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: August 31, 1999
    Assignee: Novo Nordisk
    Inventors: Preben Houlberg Olesen, Anders Kanstrup
  • Cis-3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
    Patent number: 5919817
    Abstract: The present invention relates to therapeutically active compounds of formula I ##STR1## a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related diseases or syndromes.
    Type: Grant
    Filed: October 27, 1997
    Date of Patent: July 6, 1999
    Assignee: Novo Nordisk A/S
    Inventors: Poul Jacobsen, Svend Treppendahl, Paul Stanley Bury, Anders Kanstrup, Lise Brown Christiansen
  • Antagonists, their preparation and use
    Patent number: 5783575
    Abstract: The present invention relates to therapeutically active non competitive antagonists, acting selectively at the metabotropic glutamate receptor. The novel compounds are useful in treating diseases in the central nervous system by modulating synaptic transmission via the metabotropic glutamate receptor.
    Type: Grant
    Filed: July 31, 1995
    Date of Patent: July 21, 1998
    Assignee: Novo Nordisk A/S
    Inventors: Palle Jakobsen, Anders Kanstrup, Peter Faarup, Preben H. Olesen, Jane Marie Lundbech
  • Indole compounds and their use in treating diseases of the central nervous system
    Patent number: 5696148
    Abstract: The present invention relates to therapeutically active indole compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system related to the metabotropic glutamate receptor system.
    Type: Grant
    Filed: November 18, 1996
    Date of Patent: December 9, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Jane Marie Lundbech, Anders Kanstrup
  • Thieno[2,3-b-indole derivatives and their use for treating central nervous system diseases related to the metabotropic glutamate receptor system
    Patent number: 5536721
    Abstract: The present invention relates to therapeutically active heterocyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating diseases in the central nervous system related to the metabotropic glutamate receptor system.
    Type: Grant
    Filed: March 14, 1995
    Date of Patent: July 16, 1996
    Assignee: Novo Nordisk A/S
    Inventors: Palle Jakobsen, Anders Kanstrup, Peter Faarup, Preben H. Olesen
  • Piperidine compounds for treating anoxia, cerebral ischemia migraine or epilepsy
    Patent number: 5328917
    Abstract: The present invention relates to piperidine derivatives of the formula: ##STR1## wherein, R, R.sup.1, R.sup.3, X, and n are defined in the specification, pharmaceutical compositions thereof and methods of treating anoxia, traumatic injury, ischemia, migraine and epilepsy.
    Type: Grant
    Filed: May 20, 1993
    Date of Patent: July 12, 1994
    Assignee: Novo Nordisk A/S
    Inventors: Palle Jakobsen, Anders Kanstrup, Jane M. Lundbeck